Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Wise

Showing results (311-320 of 361) with videos related to

Pageof 37
Sort By:
Journal of Medicinal Chemistry|May 31, 2002
A new type of prodrug of catecholamines: an opportunity to improve the treatment of Parkinson's diseaseBastiaan J Venhuis, Nienke Rodenhuis, Håkan V Wikström, et al.
Psychiatry Research|June 1, 1981
A biochemical study of tardive dyskinesia in young male patientsD V Jeste, L E DeLisi, S Zalcman, et al.
IEEE Transactions on Bio-Medical Engineering|July 1, 1989
Batch-fabricated thin-film electrodes for stimulation of the central auditory systemD J Anderson, K Najafi, S J Tanghe, et al.
IEEE Transactions on Bio-Medical Engineering|June 19, 2015
Chronic In Vivo Evaluation of PEDOT/CNT for Stable Neural RecordingsTakashi D Y Kozai, Kasey Catt, Zhanhong Du, et al.
The Journal of Clinical Psychiatry|February 1, 1981
Lymphocyte monoamine oxidase and plasma prolactin and growth hormone in tardive dyskinesiaD V Jeste, L M Neckers, R L Wagner, et al.
Peptides|January 1, 1995
Differential effects of the nonpeptide neurotensin antagonist, SR 48692, on the pharmacological effects of neurotensin agonistsT A Pugsley, H C Akunne, S Z Whetzel, et al.
Journal of Medicinal Chemistry|January 17, 1997
3-[[(4-Aryl-1-piperazinyl)alkyl]cyclohexyl]-1H-indoles as dopamine D2 partial agonists and autoreceptor agonistsD J Wustrow, W J Smith, A E Corbin, et al.
Neuropharmacology|April 13, 2000
PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT(1A) agonist actions. II. Preclinical behavioral effectsA E Corbin, L T Meltzer, F W Ninteman, et al.
Biochemical Pharmacology|April 18, 1995
Agonist properties of a stable hexapeptide analog of neurotensin, N alpha MeArg-Lys-Pro-Trp-tLeu-Leu (NT1)H C Akunne, S B Demattos, S Z Whetzel, et al.
Journal of Medicinal Chemistry|May 1, 1985
1-[3-(Diarylamino)propyl]piperidines and related compounds, potential antipsychotic agents with low cataleptogenic profilesL D Wise, I C Pattison, D E Butler, et al.
Pageof 37

Showing results (311-320 of 361) with videos related to

Sort By:
Pageof 37
Journal of Medicinal Chemistry|May 31, 2002
A new type of prodrug of catecholamines: an opportunity to improve the treatment of Parkinson's diseaseBastiaan J Venhuis, Nienke Rodenhuis, Håkan V Wikström, et al.
Psychiatry Research|June 1, 1981
A biochemical study of tardive dyskinesia in young male patientsD V Jeste, L E DeLisi, S Zalcman, et al.
IEEE Transactions on Bio-Medical Engineering|July 1, 1989
Batch-fabricated thin-film electrodes for stimulation of the central auditory systemD J Anderson, K Najafi, S J Tanghe, et al.
IEEE Transactions on Bio-Medical Engineering|June 19, 2015
Chronic In Vivo Evaluation of PEDOT/CNT for Stable Neural RecordingsTakashi D Y Kozai, Kasey Catt, Zhanhong Du, et al.
The Journal of Clinical Psychiatry|February 1, 1981
Lymphocyte monoamine oxidase and plasma prolactin and growth hormone in tardive dyskinesiaD V Jeste, L M Neckers, R L Wagner, et al.
Peptides|January 1, 1995
Differential effects of the nonpeptide neurotensin antagonist, SR 48692, on the pharmacological effects of neurotensin agonistsT A Pugsley, H C Akunne, S Z Whetzel, et al.
Journal of Medicinal Chemistry|January 17, 1997
3-[[(4-Aryl-1-piperazinyl)alkyl]cyclohexyl]-1H-indoles as dopamine D2 partial agonists and autoreceptor agonistsD J Wustrow, W J Smith, A E Corbin, et al.
Neuropharmacology|April 13, 2000
PD 158771, a potential antipsychotic agent with D2/D3 partial agonist and 5-HT(1A) agonist actions. II. Preclinical behavioral effectsA E Corbin, L T Meltzer, F W Ninteman, et al.
Biochemical Pharmacology|April 18, 1995
Agonist properties of a stable hexapeptide analog of neurotensin, N alpha MeArg-Lys-Pro-Trp-tLeu-Leu (NT1)H C Akunne, S B Demattos, S Z Whetzel, et al.
Journal of Medicinal Chemistry|May 1, 1985
1-[3-(Diarylamino)propyl]piperidines and related compounds, potential antipsychotic agents with low cataleptogenic profilesL D Wise, I C Pattison, D E Butler, et al.
Pageof 37